Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability

Comparison of essential medicines lists in 137 countries

(2019) Nav Persaud et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults

(2019) Pascal Geldsetzer et al.   LANCET

Fixed-dose combinations for hypertension

(2018) Sandeep P Kishore et al.   LANCET

Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey

(2017) Meng Su et al.   LANCET

Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases

(2017) Margaret Ewen et al.   PLoS One

Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries

(2016) Veronika J. Wirtz et al.   CIRCULATION

Global Disparities of Hypertension Prevalence and ControlClinical Perspective

(2016) Katherine T. Mills et al.   CIRCULATION

Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data

(2016) Rasha Khatib et al.   LANCET

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015) Mohammad H Forouzanfar et al.   LANCET

Polypills

(2014) Mark D. Huffman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Essential Medicines Are More Available than Other Medicines around the Globe

(2014) Yaser T. Bazargani et al.   PLoS One

Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review

(2013) Amir Shroufi et al.   BMC PUBLIC HEALTH

Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries

(2013) Clara K. Chow   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration

(2013) Hans V Hogerzeil et al.   LANCET

Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data

(2010) Maaike SM van Mourik et al.   BMC Cardiovascular Disorders

Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO’s model list of essential medicines

(2010) Marc Twagirumukiza et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis

(2008) A Cameron et al.   LANCET